521 related articles for article (PubMed ID: 30030349)
21. Cleaning Validation: Complete Guide for Health - Based Approach in Chemical Cross - Contamination Risk Assessment.
Tanyous JN
PDA J Pharm Sci Technol; 2019; 73(2):204-210. PubMed ID: 30361288
[TBL] [Abstract][Full Text] [Related]
22. The evolution of down-scale virus filtration equipment for virus clearance studies.
Wieser A; Berting A; Medek C; Poelsler G; Kreil TR
Biotechnol Bioeng; 2015 Mar; 112(3):633-7. PubMed ID: 25220795
[TBL] [Abstract][Full Text] [Related]
23. A mechanistic study of Protein A chromatography resin lifetime.
Jiang C; Liu J; Rubacha M; Shukla AA
J Chromatogr A; 2009 Jul; 1216(31):5849-55. PubMed ID: 19539295
[TBL] [Abstract][Full Text] [Related]
24. High throughput determination of cleaning solutions to prevent the fouling of an anion exchange resin.
Elich T; Iskra T; Daniels W; Morrison CJ
Biotechnol Bioeng; 2016 Jun; 113(6):1251-9. PubMed ID: 26552005
[TBL] [Abstract][Full Text] [Related]
25. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
Mahajan E; George A; Wolk B
J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
[TBL] [Abstract][Full Text] [Related]
26. Lifetime and Aging of Chromatography Resins during Biopharmaceutical Manufacture.
Nweke MC; Rathore AS; Bracewell DG
Trends Biotechnol; 2018 Oct; 36(10):992-995. PubMed ID: 29370932
[TBL] [Abstract][Full Text] [Related]
27. Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System.
Oni Y; Song X; Schrader M; Kulshrestha A; Franck J; Asselta R; Flores-Crespo C; Mantri RV
PDA J Pharm Sci Technol; 2019; 73(6):572-587. PubMed ID: 31101708
[TBL] [Abstract][Full Text] [Related]
28. Cleaning characterization of protein drug products using UV-vis spectroscopy.
Rathore N; Qi W; Ji W
Biotechnol Prog; 2008; 24(3):684-90. PubMed ID: 18426244
[TBL] [Abstract][Full Text] [Related]
29. Investigation of an alternative approach for real-time cleaning verification in the pharmaceutical industry.
Sarwar A; McSweeney C; Smith M; Timmermans J; Moore E
Analyst; 2020 Nov; 145(22):7429-7436. PubMed ID: 32955041
[TBL] [Abstract][Full Text] [Related]
30. Demonstrating β-glucan and yeast peptide clearance in biopharmaceutical downstream processes.
Jiang C; Scherfner S; Dick LW; Mahon D; Qiu D; Cheng KC; Shukla AA
Biotechnol Prog; 2011; 27(2):442-50. PubMed ID: 21365784
[TBL] [Abstract][Full Text] [Related]
31. Determination of robustness and optimal work conditions for a purification process of a therapeutic recombinant protein using response surface methodology.
Amadeo I; Mauro LV; Ortí E; Forno G
Biotechnol Prog; 2011; 27(3):724-32. PubMed ID: 21574264
[TBL] [Abstract][Full Text] [Related]
32. Analytical tools for monitoring changes in physical and chemical properties of chromatography resin upon reuse.
Pathak M; Lintern K; Johnson TF; Nair AM; Mukherji S; Bracewell DG; Rathore AS
Electrophoresis; 2019 Dec; 40(23-24):3074-3083. PubMed ID: 31562772
[TBL] [Abstract][Full Text] [Related]
33. Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing.
Mathaes R; Mahler HC; Roggo Y; Huwyler J; Eder J; Fritsch K; Posset T; Mohl S; Streubel A
PDA J Pharm Sci Technol; 2016; 70(2):109-19. PubMed ID: 26797971
[TBL] [Abstract][Full Text] [Related]
34. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
35. Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development.
Zingaro K; Shaw D; Carson J; Mayer-Bartschmid A; Bender C; Alves C; Mcvey D; Qian NX; Wei Q; Laird MW; Zhu Y; Emmins R; Follit JA; Porter A; Racher AJ; Milne S; Carubelli I; Du Z; Khatri A; Failly M; Broly H; Lee F; Reeser M; Spidel J; Anderson K; Demaria C; Di-Carlo J; Gill J; Lundquist A; Kumar SR; Gill T
PDA J Pharm Sci Technol; 2018; 72(4):438-450. PubMed ID: 29669815
[TBL] [Abstract][Full Text] [Related]
36. Bacteriophage and impurity carryover and total organic carbon release during extended protein A chromatography.
Lute S; Brorson K
J Chromatogr A; 2009 May; 1216(18):3774-83. PubMed ID: 19285678
[TBL] [Abstract][Full Text] [Related]
37. Current issues in validation of chromatography.
Sofer G
Dev Biol (Basel); 2003; 113():61-4. PubMed ID: 14620853
[TBL] [Abstract][Full Text] [Related]
38. Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts.
Denk R; Flückiger A; Kisaka H; Krause S; Maeck R; Restetzki L; Schreiner A; Schulze R
PDA J Pharm Sci Technol; 2019; 73(5):487-495. PubMed ID: 31420508
[TBL] [Abstract][Full Text] [Related]
39. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
Gikanga B; Chen Y; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
[TBL] [Abstract][Full Text] [Related]
40. Manufacturing process for antithrombin III concentrate: viral validation studies and effects of column re-use on viral safety.
Falbo A
Dev Biol (Basel); 2003; 113():81-8. PubMed ID: 14620856
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
